



The liver plays a central role in metabolic proc-
esses such as the synthesis of serum proteins 
(e.g. albumin), storage of glycogen, maintaining 
homeostasis, and immunological functions [1].  
The most notable characteristic of the liver is its 
regenerative ability and investigations have 
shown that the liver can regenerate to its full 
size even after a 67% hepatectomy [2-3].  Addi-
tionally, studies have shown that liver transplan-
tations into comparatively larger or smaller re-
cipients resulted in the transplanted liver ad-
justing to the appropriate size needed for the 
recipient. The liver’s unique regenerative capac-
ity is often impeded when it is seriously dis-
eased or damaged. Chronic liver injury impairs 
the liver’s functions by causing extracellular 
matrix proteins such as fibrillar collagens type I 
and type III to accumulate, while the liver at-
tempts to regenerate itself [4-5]. An increased 
production of collagen fibers, known as fibrosis, 
is caused by the activation of hepatic stellate 
cells (HSC), which proliferate and undergo colla-
gen synthesis [6]. Persistent injury to the liver by 
alcohol abuse or hepatitis B and C, will trans-
form the liver architecture, into an irregularly 
nodular rather than a uniformly smooth organ 
[5, 7]. At advanced stages of liver disorder, the 
end stage of liver failure is known as cirrhosis, 
where liver transplants or hepatocyte transplan-
tations are the only options for survival [5, 8].  
Since not every patient with liver disease imme-
diately qualifies for transplant surgery, alterna-
tive treatments are used to delay the progres-
sion of the disease or even reverse it [9-10]. 
 
Potential therapies to regenerate damaged liver 
tissue and improve its function include stem cell 
therapy, which has stirred immense interest 
because of their capacity of self-renewal and 
multipotency [11]. Investigators have found 
promising results showing human and mouse 
embryonic stem (ES) cells and adult stem cells 
derived from bone marrow, skin, adipose tissue 
and even the liver can differentiate in vitro into 
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hepatocyte-like cells [12-15].  In vivo experi-
ments have proven that murine ES cells can 
incorporate themselves into hepatectomized 
livers [16-17]. Unfortunately, the limitation of 
using ES cells is their potential to develop tera-
tomas after transplantation. However, the inci-
dence for this occurrence was reduced as ES 
cells from embryoid bodies were allowed to dif-
ferentiate into hepatocyte-like cells [18]. Adult 
stem cells have also been used to enhance re-
generation of hepatectomized livers derived 
from bone marrow and adipose tissue, where 
results did not indicate teratoma formation or 
immune-rejection from autologous transplanta-
tion [19-21].    
 
One group of stem cells isolated from post-natal 
skeletal muscle tissue has been investigated for 
its impressive mutlilineage differentiation ca-
pacity and self-renewal ability [22]. These cells 
were isolated from muscle tissue using a modi-
fied preplate technique by enzymatic dissocia-
tion from a muscle biopsy and divided into 6 
populations, based on adhesion characteristics 
in collagen coated flasks [23-24]. Later pre-
plates were regarded as muscle derived stem 
cells (MDSCs) and identified using flow cytome-
try for the expression of stem cell antigen 1 
(Sca1), CD34, fetal liver kinase 1 (Flk1) and 
measurable amounts of desmin, but not c-kit 
nor CD45 [22, 25-26]. Experimental studies 
have demonstrated the multipotency of MDSCs 
through differentiation into cell lineages of the 
three germ layers: mesoderm, ectoderm and 
endoderm. Multiple investigations have re-
vealed differentiation of MDSCs along the 
mesoderm lineage into osteocytes, adipocytes, 
chondrocytes and hematopoietic cells [25, 27-
29].  Other studies have demonstrated MDSCs 
differentiation into ectoderm cell lineages by 
detecting the expression of both neuronal and 
glial cell markers. Differentiation along the 
same germ layer as hepatocytes, the endoderm, 
has been observed through differentiation into 
urinary bladder cells for the purpose of treating 
patients suffering from urinary incontinence [30
-33]. The non-invasive isolation procedure of 
MDSCs has made them advantageous for self-
autologous cell transplantation therapies. The 
purpose of this study was to examine the ability 
of MDSCs to differentiation into liver-like cells 
through co-culturing with hepatocyte cell-lines 
and identifying their expression of specific liver 
cell markers.  Furthermore, in vivo studies were 
used to determine whether MDSCs could suc-
cessfully engraft into hepatectomized mouse 
livers for repair.     
  
Materials  and methods 
 
MDSCs isolation and culture 
 
Muscle tissue was isolated from the gastrocne-
mius muscle of C5710J, wildtype neonatal male 
mice (3 - 4 weeks old). MDSCs isolation was 
performed by tissue digestion using a series of 
collagenase, dispase, and trypsin enzymes. 
Separation was performed based on their adhe-
sion characteristics using a modified preplate 
technique [23-24]. Following isolation, a pre-
plated population of MDSCs was cultured in 
proliferation media made of Dulbecco’s Modi-
fied Eagle Medium (DMEM) supplemented with 
10% Fetal Bovine Serum (FBS), 10% Horse Se-
rum (HS), 1% Penicillin-Streptomycin (P/S) anti-
biotics, and 0.5% chicken embryo extract (CEE); 
and incubated in 5% CO­2 at 37oC.  
 
Retroviral LacZ transfection 
 
A LacZ retrovirus was isolated from the Tel-6 
cell line with a titer of 8x107 and diluted with 
proliferation medium [35]. 1 μg/mL of poly-
brene stock solution (8 mg/mL) was added for a 
final concentration of 8 μg/mL polybrene.  This 
mixture was added to the MDSCs and incubated 
at 37C for 6 hours. This process was repeated 
three times to ensure maximal yield gene trans-




LacZ staining was performed by fixing cells with 
buffered 4% formalin for 5 minutes.  Afterward, 
cells were incubated with X-gal diluted 1:50 in 
the LacZ staining solution (K4Fe(CN)6 
[0.5mmol/L], K3Fe(CN)6 [0.5 mmol/L], MgCl2 
[1.0 mmol/L]) for 2 hours at 37oC.  LacZ posi-
tive cells will express beta-galactosidase (β-Gal) 
and appear blue under bright field microscopy 
[35]. 
 
Liver cell line culture 
 
Mouse hepatocyte, AML12 (ATCC, Manassas, 
VA) and tumor hepatocyte lines, Hepa1-6 (ATCC, 
Manassas, VA) were cultured in DMEM and 
Ham’s F-12 medium at a 1:1 ratio with 10% 
FBS, 1% P/S, 5μg/mL insulin, 5 μg/mL transfer-
rin, 5 ng/mL sodium selenite and 40 ng/mL 
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MDSCs were plated in a multi-well dish with 
either AML12 or Hepa1-6 cells at a ratio of 1:10 
(MDSCs:hepatocyte cell line). All cells in the 
multi-well were incubated with liver cell medium 
(described above) for periods of 1 and 7 days at 
37C and 5% CO2.  MDSCs and hepatocyte lines 
were also co-cultured using a transwell setup, 
where MDSCs were plated on 24 mm diameter 
transwells with 0.4 µm pore size (Corning Inc., 
NY) placed within a 6 multi-well dish.  The hepa-
tocyte cell lines were placed in the bottom of 
separate wells in the multi-well dish.     
 
Immunocytochemistry   
 
Cells were fixed with 4 % formalin for 5 minutes 
at room temperature with unspecific binding 
blocked using HS for 1 hour.  Primary antibodies 
(anti-albumin [1:100, ICN Biomedicals], anti-
alpha fetoprotein(αFP) [1:200, Santa Cruz], anti
-HNF-4α [1:200, Santa Cruz]) diluted in PBS 
with 2% HS were incubated overnight at 4C.  
Cells were incubated with secondary antibodies 
(Alexa Fluor 488 anti-rabbit Ab [1:200, Invitro-
gen Molecular Probes], Alexa Fluor 488 anti-
mouse Ab [1:200, Invitrogen Molecular Probes], 
Cy3 anti-goat Ab [1:200, Sigma]) the following 
day for 1 hour at room temperature. 4’,6-
diamidine-2-phenylindole (DAPI) was diluted in 
PBS (100 ng/mL) and administered for 5 min-
utes.  Between each step, cells were washed 
with PBS. All cells were visualized using a Leica 
DM IRB fluorescent microscope.   
 
Reverse-Transcription Polymerase Chain Reac-
tion (RT-PCR) 
 
Total RNA was extracted from the cultured 
MDSCs using the RNeasy plus mini kit (Qiagen), 
and complimentary DNA was generated using 
the reverse transcription kit (Retroscript, Ambi-
ent Bio Systems) as per the manufacturer’s in-
structions. Polymerase chain reaction (PCR) 
amplifications were performed using specific 




Cell transplantations were performed on 6-8 
week old female Nod/LtSz-Prkdcscid mice (The 
Jackson Laboratory).  Initially, mice underwent a 
50% hepatectomy, removing left and median 
lobes, and cells were infused immediately fol-
lowing the surgical procedure through the tail 
vein. Each mouse received approximately 106 
male mouse LacZ-MDSCs. At various time 
points (3, 7, and 90 days) after cell injections, 
mice were euthanized, and the liver was col-
lected for histological analysis.   
 
Fluorescence in situ hybridization (FISH) 
 
FISH was performed on sectioned livers as de-
scribed previously by Matsumoto et al [36].  
Briefly, the mouse Y-chromosome-specific probe 
directly labeled with FITC (ID Laboratories,    
Tables. Primer Used 
αFP S: 5’ – GTGAAACAGACTTCCTGGTCCT – 3’ 
A: 5’ – GCCCTACAGACCATGAAACAAG – 3’ 
Albumin  S: 5’ – TCAACTGTCAGAGCAGAGAAGC – 3’ 
A: 5’ – AGACTGCCTTGTGTGGAAGACT – 3’ 
CK18 S: 5’ – TGGTACTCTCCTCAATCTGCTG – 3’ 
A: 5’ – CTCTGGATTGACTGTGGAAGTG – 3’ 
G6P S: 5’ – CAGGACTGGTTCATCCTT – 3’ 
A: 5’ – GTTGCTGTAGTAGTCGGT – 3’ 
HNF1α  S: 5’ – TTCTAAGCTGAGCCAGCTGCAGACG – 3’ 
A: 5’ – GCTGAGGTTCTCCGGCTCTTTCAGA – 3’ 
TAT S: 5’ – TCCCGACTGGATAGGTAG – 3’ 
A: 5’ – ACCTTCAATCCCATCCGA – 3’ 
GAPDH S: 5’ – CCTCTGGAAAGCTGTGGCGT – 3’ 
A: 5’ – TTGGCAGGTTTCTCCAGGCG – 3’ 
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London, Ontario) and a hybridization mixture 
were denatured at 75oC for 10 minutes and 
allowed to reanneal for 60-90 minutes at 37oC 
following a modification of the manufacturer's 
protocol. Ten microliters of this mixture was 
applied to the target area and a plastic cover 
slip applied carefully. The edges of the cover 
slip were sealed with rubber cement to prevent 
evaporation. The slides were stored in a humid 
chamber at 37oC for 18-24 hours. On day 2, the 
cover slips were removed and the slides were 
washed by several steps of 2× sodium chloride-
sodium citrate (SSC) for 1 minute and 50% For-
mamide-2×SSC for 12 minutes and 2×SCC-1% 
Tween mixture for 5 minutes at 45oC. The nuclei 
were revealed by counterstaining with DAPI 
stain (100 ng/ml; Sigma), and all sections were 
mounted with Vectashield medium (Vector). The 
hybridized Y-chromosome specific probe was 





MDSCs differentiation into hepatocyte-like cells 
by direct cell co-culture 
 
LacZ-MDSCs were plated in a 12 multiwell dish 
at a 1:10 ratio with a normal mouse hepatocyte 
cell line (Figure 1), AML12, or a tumurigenic 
mouse hepatocyte cell line, Hepa1-6 (Figure 2).  
After 1 and 7 days of co-culture, cells were fixed 
and fluorescently labeled with liver specific cell 
markers.  Images A, C, E, G, I, and K of figures 1 
Figure 1. Bright field (A, C, E, G, I, K) and fluorescent microscopy (B, D, F, H, J, L) images demonstrating MDSCs differ-
entiation into hepatocyte-like cells when co-cultured with the AML12 hepatocyte cell line after 1 day (A, B, E, F, I, J) 
and 7 days (C, D, G, H, K, L).  In the bright field images, MDSCs are denoted by β-galactosidase expression (blue) and 
by black arrows whereas in fluorescent images, they are denoted by white arrows at the same location.  In the fluo-
rescent images, the co-cultured cells are stained for albumin (green: B, D), HNF4α (green: F, H) and αFP (red: J, L). 
The cell nuclei were stained with DAPI (blue).      
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and 2 were taken using bright field microscopy 
indicating β-galactosidase (blue) positive 
MDSCs, while images B, D, F, H, J, and L were 
taken at the same respective locations using 
fluorescent microscopy. After 1 day in co-culture 
with either of the hepatocyte cell lines, MDSCs 
did not express albumin as illustrated in figure 
1B and 2B.  By day 7 of co-culture, however, 
MDSCs begun expressing albumin (green), as 
shown in Figures 1D and 2D.      
 
Similar results were found for MDSCs labeled 
for hepatocyte nuclear factor 4 alpha (HNF4α) 
as shown in Figures 1 and 2, E through H. On 
day 7 of co-culturing MDSCs with either AML12 
or Hepa1-6 cells, MDSCs began expressing 
HNF4α in the cell nucleus, as shown in Figure 
1H and 2H with the white arrows. HNF4α is a 
nuclear transcription factor that binds to DNA as 
a homodimer to control the expression of sev-
eral genes including the hepatocyte nuclear 
factor 1 (HNF1α), which is another transcription 
factor that regulates the expression of several 
hepatic genes. In comparison with day 7, 
MDSCs co-cultured with either AML12 (Figures 
1E & 1F) or Hepa1-6 (Figures 2E & 2F) cells for 
only 1 day were negative for HNF4α expression, 
where black arrows show the location for the β-
galactosidase positive MDSCs (Figures 1E & 2E) 
in relation to the mouse liver cells, and the 
white arrows show the location of the MDSCs 
(Figure 1F & 2F). 
 
αFP expression with muscle derived stem cells 
is shown in Figure 1 when co-cultured with 
AML12 cells. On day 1 of co-culture, β-
galactosidase positive MDSCs (Figure 1I, black 
arrow) do not express αFP (Figure 1J), while the 
cell nuclei are stained with DAPI (blue). By day 
7, MDSCs began to express αFP, similarly to the 
AML12 cells (Figures 1K & 1L).   
 
MDSCs differentiation into hepatocyte-like cells 
using transwell cell co-culture 
 
Using a transwell setup, hepatocyte cell lines, 
AML12 or Hepa1-6 plated at the bottom of well 
dishes were separated from MDSCs by transwell 
inserts and co-cultured for either 1 or 7 days 
(Figure 3A). The temporal expression of hepato-
cyte marker genes, such as αFP, albumin, 
CK18, G6P, TAT and hepatocyte nuclear factor 
(HNF)-1α were analyzed by RT-PCR (Figure 3B).  
The expression of these liver marker genes in 
MDSCs alone was very minimal, except in CK18 
and TAT, where their expression was not de-
Figure 2. Bright field (A, C, E, G) and fluorescent microscopy (B, D, F, H) images demonstrating MDSCs differentiation 
into hepatocyte-like cells when co-cultured with the Hepa1-6 hepatocyte cell line after 1 day (A, B, E, F) and 7 days (C, 
D, G, H).  MDSCs are denoted by β-galactosidase expression (blue) and black arrows in bright field microscopy im-
ages.  Fluorescent images, were taken at the exact location, where MDSCs are denoted by white arrows and stained 
for albumin (green: B, D) and HNF4α (red: F, H). The cell nuclei were stained with DAPI (blue).       
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tected. One day following the co-culture of 
MDSCs with both hepatocyte cell lines, the ex-
pression of all the liver marker genes was no-
ticeably upregulated. However, after 7 days of 
co-culture, the expression of most genes was 
reduced in MDSCs, with the exception of MDSCs 
co-cultured with AML12 cells, where CK18 ex-
pression increased (Figures 3C & 3D). GAPDH 
Figure 3. Representation of the transwell co-culture setup where MDSCs were placed in the transwell and the hepato-
cyte cell lines (AML12 and Hepa1-6) were placed in the bottom of the multiwell dish. Gene expression profile of 
mouse MDSCs co-culture with either AML12 (Day 1 – A and Day 7 - A) or Hepa1-6 (Day 1 – H and Day 7 - H) hepato-
cyte cell lines using a transwell plate after 1 and 7 days (B).  The expression of hepatocyte cell markers in MDSCs 
when co-cultured with AML12 (C) and Hepa1-6 (D) cell lines for different periods of time are shown with normalization 
to the loading control, GAPDH.          
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was used as a loading control. 
 
MDSCs differentiation into hepatocyte-like cells 
in vivo  
 
Male LacZ-MDSCs were transplanted (106 cells) 
into 6-8 week old female mice through the tail 
vein following a 50% hepatectomy to remove 
the left and median lobes of the liver. Three and 
7 days after cell transplantation, mice were 
euthanized, and their livers were extracted.  
Livers were sectioned onto slides and stained 
for β-galactosidase (blue) at both 3 (Figure 4A) 
and 7 (Figure 4C) days after cell transplanta-
tion. MDSCs also began expressing liver specific 
marker, albumin (red), 3 (Figure 4B) and 7 
(Figure 4D) days after transplantation. These 
results demonstrate MDSCs survival and en-
graftment into the remaining liver tissue after 
the partial hepatectomy. 
 
After 3 months following liver hepatectomy and 
MDSCs transplantation, mouse livers were ex-
tracted and sectioned to examine long term cell 
survival. As illustrated in Figure 4E, sectioned 
mouse livers were subjected to hemotoxylin and 
eosin staining and stained for β-galactosidase.  
The positive expression of β-galactosidase (dark 
blue) indicated the presence of MDSCs within 
the liver after 3 months from the initial cell 
transplantation. Magnification of this is shown 
in the inset of Figure 4E. As described above, 
the donor MDSCs were obtained from male mice 
and injected into female mice 24 hours following 
partial hepatectomy. FISH analysis revealed Y 
chromosomes within the nuclei of hepatocytes 
(albumin-positive cells) within the injured liver 
tissue of female recipients (Figures 4F & 4G), 7 




A number of studies have examined the differ-
entiation of adult and embryonic stem cells iso-
lated from mice and humans into hepatocyte-
like cells [12-15]. Generally, the methods used 
to differentiate stem cells can be divided into 
several categories, including different serum-
free and serum-rich medias, co-culture with 
hepatocyte-like cells, transfection of a liver-
specific gene through a viral vector or a combi-
nation of growth factors [37-43]. Both types of 
stem cells, when transplanted into the animal 
recipients, were found to improve the function 
of damaged livers. While adult stem cells are a 
promising option for cellular transplantations 
since they do not invoke an immune response, 
Figure 4. MDSCs differentiate into liver-like cells in 
vivo.  Images of liver tissue harvested 3 days after 
MDSCs transplantation and stained for β-
galactosidase (A, blue) or albumin (B, red).  Similarly, 
liver tissue harvested 7 days after MDSC transplan-
tation was also stained for β-galactosidase (C, blue) 
or albumin (D, red).  Long term MDSCs engraftment 
into hepatectomized livers was observed after 3 
months (E).  As indicated by the black arrows, β-
galactosidase positive (blue) MDSCs are found in the 
liver tissue subjected to hemotoxylin and eosin stain-
ing.  A magnified image is shown in the inset of this 
figure.  FISH analysis revealing the donor signal (Y-
chromosome) within injured liver tissue of female 
recipients, 7 days after male MDSCs were trans-
planted (F, G).  MDSCs were stained for cell nuclei, 
blue; Y-chromosome, green; and albumin, red.   
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they are, however, challenged by the limited 
number of stem cells that may be isolated from 
a patient’s tissue [44]. The benefit of MDSCs for 
cell based therapies is their easy accessibility 
through non-invasive procedures and multi-
differentiation capacity. The MDSCs used in this 
report have previously been demonstrated to 
have the multipotency characteristic of stem 
cells by differentiating into myogenic, hemato-
poietic, osteogenic, adipogenic, chondrogenic, 
neural and endothelial cells [30].   
 
In the present study, MDSCs demonstrated their 
potential to differentiate into hepatocyte-like 
cells using a co-culture system with two differ-
ent liver cell types. The results of our immunocy-
tochemistry investigations (Figure 1 & 2) illus-
trated the MDSCs protein expression is similar 
to that of AML12 and Hepa1-6 cells. Day 1 of 
MDSCs co-cultured with AML12 or Hepa1-6 
cells showed no expression of liver marker pro-
teins: albumin, αFP, and HNF-4α. At longer 
times of co-culturing (7 days), MDSCs had com-
parable expression of liver specific proteins to 
both hepatocyte cell lines. Because we initially 
transfected the MDSCs with a LacZ viral vector, 
we were able to distinguish MDSCs from the 
hepatocytes.  Furthermore, these images show 
no indication of cell fusion of a β-galactosidase 
positive MDSCs with LacZ negative cell hepato-
cytes. Our qualitative results demonstrate that 
MDSCs differentiate into liver-like cells without 
fusion, as mentioned in previous publications 
where hematopoietic stem cells and bone mar-
row derived cells were shown to differentiate 
into hepatocyte-like cells of rodents [20, 45]. 
However, conflicting data has also indicated 
that transplanted bone marrow cells aid in re-
generating the damaged livers of mice through 
fusion with local hepatocytes [46-47]. While the 
use of similar cell types repaired liver damage 
through two different mechanisms (fusion/no 
fusion), ultimately the model used for liver dam-
age may influence the regenerative process of 
the transplanted cells. For instance, in the stud-
ies where transplanted cells facilitated regen-
eration by cell fusion and not differentiation, 
FAH-deficient mice were examined. Thus, the 
observed fusion most likely resulted from a ge-
netic alteration. In studies where cell differentia-
tion contributed to liver repair, the damaged 
liver model under investigation was either a 
partial hepatectomy or chemically induced liver 
damage by carbon tetrachloride. These results 
suggest that perhaps adult stem cells have dif-
ferent fundamental signaling patterns to deter-
mine which underlying mechanism is impaired 
and proceed with the proper method to restore 
function to the liver.   
 
The results of the transwell co-culture further 
provide evidence that the MDSCs begin to ex-
press hepatocyte cell markers when not in con-
tact with two different hepatocyte cell lines 
(AML12 and Hepa1-6). As early as 1 day follow-
ing co-culture, an upregulation in the RNA of 
liver cell markers are found within MDSCs. By 
day 7 of co-culture, the upregulation of liver cell 
marker RNA has subsided. Our data show that 
during the early stages of co-culture, the RNA 
expression is influenced to increase dramati-
cally, which promoted protein expression sev-
eral days later. This initial increase in the liver 
cell markers at the RNA level actively causes 
the MDSCs to differentiate into a liver cell and 
to maintain its protein expression of hepatocyte 
markers. Once the MDSCs are activated for 
hepatocyte differentiation, an elevated expres-
sion of liver cell markers at the RNA level are no 
longer needed to maintain the protein expres-
sion. 
 
These studies have provided evidence that 
stem cells derived from adult tissue can differ-
entiate and aid in the regeneration of injured 
livers. Cell migration and proliferation during 
liver tissue regeneration is often impaired by the 
presence of fibrosis [8]. In order to properly re-
store the function of the liver, it would be essen-
tial to combine the beneficial attributes of stem 
cell regeneration with alternative means to re-
duce fibrotic scar tissue. Matrix metallopro-
teinases (MMPs) have been identified as a valu-
able source in remodeling damaged tissue by 
promoting cell migration, proliferation, and dif-
ferentiation, as well as degrading fibrotic scar 
tissue [48-49]. While MMPs are highly ex-
pressed by injured livers during repair, MDSCs 
appear as suitable candidates for cell based 
therapies of the liver, not only for their capacity 
to differentiate into hepatocyte-like cells, but 
because of their expression of MMPs (data not 
shown) [2, 50]. MDSCs, as demonstrated in our 
studies, can differentiate into cells along the 
endoderm lineage and actively promote tissue 
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